Prevalence of the Helicobacter pylori infection in chronic urticaria
DOI:
https://doi.org/10.66344/jpad.v20i3.407Keywords:
Helicobacter pylori, urticaria, angioedemaAbstract
Background Urticaria is one of the most common clinically diagnosed dermatologic diseases. Wheals and pruritus are typical presentation of disease. Correlation between chronic urticaria (CU) and Helicobacter pylori infection has been proposed by many studies previously.
Objective To confirm the correlation between H. pylori infection and CU by the anti-H. pylori immunoglobulin measurement.
Patients and methods In a case-control study, we measured serum anti- H. pylori IgG and IgA in 43 patients with CU, 10 patients with CU and angioedema and 40 normal persons as controls. Personal identity, disease duration, presence of gastrointestinal complaints, angioedema history and previous history of anti-H. pylori treatment was collected and then analyzed by the SPSS software.
Results Anti-H. pylori P IgG, anti-H. pylori P IgA and anti-H. pylori IgA plus IgG together were positive in the 72.1%, 46.5% and 44.18% of the CU patients, respectively. Among patients with CU and angioedema anti-H. pylori IgG, anti-H. pylori IgA and anti-H. pylori IgG plus IgA together were positive in the 90%, 60% and 60%, respectively. Anti-HP IgG, anti-H. pylori IgA and anti-H. pylori IgG plus IgA together were positive in the 37.5%, 40% and 27.5% of the control group, respectively. Anti-H. pylori IgG and anti-H. pylori IgG plus IgA antibodies together in the CU patients were statistically associated (P<0.002). Angioedema presentation was related to the serum anti-H. pylori IgG with the 86% accuracy confidence.
Conclusion: Our study supports the correlation between CU and H. pylori infection and H. pylori eradication therapy may have a role in the CU treatment protocol.
References
1. Bressler RB. Pathophysiology of urticaria. Immunol Allergy Clin N Am 1995: 15: 659-77.
2. Kobza Black A, Garttan CEH. The mediators involved in acute and chronic urticaria. Recent Advances in Dermatology, Vol 9. Edinburg: Churchill Livingstone; 1992. P. 119-32.
3. Wiggins CA, Dykewicz MS, Patterson R. Idiopathic anaphylaxis; classification, evaluation and treatment of 123 patients. J Allergy Clin Immunol 1988; 82: 849-55.
4. Wilkiinson JRW, Lee TH. General anaphylaxis. In: Lachmann PJ, Peters DK, Rosen FS, Walport MS, eds. Clinical Aspects of Immunology, 5th edn. Oxford: Blackwell Scientific Publications; 1993. P. 999-1014.
5. Rook AJ, Maibach HI, Juhlin L. Urticaria (special issue). Semin Dermatol 2006; 6: 272-356.
6. Garza Yado Mde L, López García AI, Paz Martínez D et al. Prevalence of seropositividad to antibodies IgG and IgM against Helicobacter pylori in the medical residents of the University Hospital of Puebla. Rev Alerg Mex 2006; 53: 69-72. Spanish
7. Di Campli C, Gasbarrini A, Nucera E et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998; 43: 1226-9.
8. Galadari IH, Sheriff MO. The role of Helicobacter pylori in urticaria and atopic dermatitis. Skinmed 2006: 5; 172-6.
9. Fiebiger E, Maurer D, Holub H et al. Serum IgG auto antibodies directed against the a chain of FcεRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995; 96: 2606-12.
10. Fiebiger E, Hammerschmid F, Stingl G, Maurer D. Anti-FcεRIα. autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998; 101: 243-51.
11. González Morales JE, Leal Villareal L, Castillo Salazar Nde J et al. Correlation entre urticaria chronica e infecci por H. pylori. Rev Alerg Mex 2005; 52: 179-82.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Majid Mogadam Rostamy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
